Mobile

A phase III, placebo controlled clinical trial to assess efficacy and safety of one dose of Dysport solution in the treatment of upper limb spasticity in adults after stroke

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000554-38

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the efficacy of Dysport Solution 1000 U compared to placebo in reducing the upper limb muscle tone (using the Modified Ashworth Scale (MAS)) in adult subjects with upper limb spastic hemiparesis due to stroke after one treatment cycle.

Critère d'inclusion

  • upper limb spastic hemiparesis due to stroke

Liens